Genelux GNLX
NASDAQ GNLX
$2.74 +0.06 (+2.24%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genelux (GNLX) Total Current Liabilities (2022 - 2026)

Genelux (GNLX) posted quarterly Total Current Liabilities of $7.3 million for Q1 2026, up 16.82% quarter-over-quarter from $6.2 million in Q4 2025.

Genelux (GNLX) Total Current Liabilities (2022 - 2026) Analysis & Trends

Genelux's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $7.3 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities changed N/A year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $7.3 million (changed N/A YoY), while the FY2025 annual figure was $6.2 million, down 9.82% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $7.3 million, up from $6.2 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $31.6 million in Q4 2022, with the low at $5.1 million in Q3 2025.
  • The 5-year median for Total Current Liabilities is $6.9 million (2024), against an average of $9.0 million.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities slumped 79.28% in 2023, then increased 20.42% in 2025.
  • Genelux's Total Current Liabilities stood at $31.6 million in 2022, then plunged by 79.28% to $6.6 million in 2023, then gained by 5.32% to $6.9 million in 2024, then decreased by 9.82% to $6.2 million in 2025, then gained by 16.82% to $7.3 million in 2026.
  • Business Quant data shows GNLX's Total Current Liabilities at $7.3 million in Q1 2026, $6.2 million in Q4 2025, and $5.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.58 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.51 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 438.74 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 630.93 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 2.49 Bn
10 Genelux 120.53 Mn 120.53 Mn - 7.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.27 Mn
Dec 31, 2025 6.23 Mn
Sep 30, 2025 5.13 Mn
Jun 30, 2025 6.99 Mn
Dec 31, 2024 6.90 Mn
Sep 30, 2024 5.56 Mn
Jun 30, 2024 5.80 Mn
Mar 31, 2024 7.81 Mn
Dec 31, 2023 6.55 Mn
Sep 30, 2023 8.76 Mn
Dec 31, 2022 31.63 Mn